These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 8464681)

  • 1. American Academy of Pediatrics Committee on School Health. Prevention of hepatitis B virus infection in school settings.
    Pediatrics; 1993 Apr; 91(4):848-50. PubMed ID: 8464681
    [No Abstract]   [Full Text] [Related]  

  • 2. Committee on Native American Child Health and Committee on Infectious Diseases. Immunizations for Native American children. American Academy of Pediatrics.
    Pediatrics; 1999 Sep; 104(3 Pt 1):564-7. PubMed ID: 10469787
    [No Abstract]   [Full Text] [Related]  

  • 3. American Academy of Pediatrics Committee on Infectious Diseases: Universal hepatitis B immunization.
    Pediatrics; 1992 Apr; 89(4 Pt 2):795-800. PubMed ID: 1557285
    [No Abstract]   [Full Text] [Related]  

  • 4. Near elimination of hepatitis B virus infections among Hawaii elementary school children after universal infant hepatitis B vaccination.
    Perz JF; Elm JL; Fiore AE; Huggler JI; Kuhnert WL; Effler PV
    Pediatrics; 2006 Oct; 118(4):1403-8. PubMed ID: 17015529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. American Academy of Pediatrics. Committee on School Health, Committee on Infectious Diseases. School attendance of children and adolescents with human T lymphotropic virus III/lymphadenopathy-associated virus infection.
    Pediatrics; 1986 Mar; 77(3):430-2. PubMed ID: 3456556
    [No Abstract]   [Full Text] [Related]  

  • 6. School Transportation Safety. American Academy of Pediatrics. Committee on School Health and Committee on Injury and Poison Prevention.
    Pediatrics; 1996 May; 97(5):754-7. PubMed ID: 8628625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of a new universal infant and school-based adolescent hepatitis B vaccination program in Australia.
    Gidding HF; Warlow M; MacIntyre CR; Backhouse J; Gilbert GL; Quinn HE; McIntyre PB
    Vaccine; 2007 Dec; 25(51):8637-41. PubMed ID: 18054127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An Advisory Committee Statement (ACS). National Advisory Committee on Immunization (NACI). Supplementary statement on hepatitis prevention.
    Can Commun Dis Rep; 1997 Sep; 23():1-6. PubMed ID: 9327646
    [No Abstract]   [Full Text] [Related]  

  • 9. Occupational transmission of hepatitis B.
    Plast Surg Nurs; 2003; 23(4):160-3. PubMed ID: 14976708
    [No Abstract]   [Full Text] [Related]  

  • 10. [Hepatitis B prevention at a school for mentally handicapped patients].
    Rohling I
    Gesundheitswesen; 1996; 58(8-9):454-8. PubMed ID: 9011261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Update: recommendations to prevent hepatitis B virus transmission--United States.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1999 Jan; 48(2):33-4. PubMed ID: 9933127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perinatal hepatitis B transmission and vaccination timing in a managed care cohort: assessment of the temporary delay in newborn hepatitis B vaccination due to thimerosal content.
    Chang S; Begier EM; Schech SD; Venus P; Shatin D; Braun MM; Ball R
    Pediatr Infect Dis J; 2007 Apr; 26(4):329-33. PubMed ID: 17414397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Education of children with human immunodeficiency virus infection: guidelines for families, health care and education personnel. Infection and Immunisation Committee of the New Zealand Paediatric Society.
    N Z Med J; 1994 Apr; 107(975):124-6. PubMed ID: 8145957
    [No Abstract]   [Full Text] [Related]  

  • 14. Public health perspective on vaccine-preventable hepatitis: integrating hepatitis A and B vaccines into public health settings.
    Hershey JH; Schowalter L; Bailey SB
    Am J Med; 2005 Oct; 118 Suppl 10A():100S-108S. PubMed ID: 16271550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IAP guidelines on optional vaccines and related matters.
    John TJ
    Indian Pediatr; 1999 Jul; 36(7):677-9. PubMed ID: 10740304
    [No Abstract]   [Full Text] [Related]  

  • 16. The virus we could defeat: a new vaccine is underused.
    Consum Rep; 1996 Apr; 61(4):88. PubMed ID: 10182462
    [No Abstract]   [Full Text] [Related]  

  • 17. [Hepatitis B outbreak in a day care center affected several families. It could have been prevented by vaccination of all children].
    Broholm KA; Sjödin L; Backlund I; Johansson B; Norder H; Magnius L
    Lakartidningen; 2001 May; 98(19):2337-8, 2341-2. PubMed ID: 11402989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Vaccination against hepatitis B].
    Madaliński K; Mikołajewicz J; Michalska Z
    Przegl Epidemiol; 1996; 50(1-2):3-14. PubMed ID: 8711156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Critical issues surrounding hepatitis B vaccination for adolescents: a roundtable.
    Brookman RR; Koff RS; Schaffner W; Margolis HS; Collins M; Bloom BS; Coupey SM
    J Adolesc Health; 1995 Oct; 17(4):208-33. PubMed ID: 8580123
    [No Abstract]   [Full Text] [Related]  

  • 20. Hepatitis B virus infection.
    Cherian T; John TJ
    Indian Pediatr; 1997 Aug; 34(8):762-3. PubMed ID: 9508557
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.